Sale!

PLXNB3 Gene Adrenoleukodystrophy x-linked Genetic Test Cost

Name: PLXNB3 Gene Adrenoleukodystrophy x-linked Genetic Test Cost
SKU: TEST-1015
Price: 3200 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 3,200 د.إ.

-43%

The PLXNB3 Gene Adrenoleukodystrophy (ALD) X-linked Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the PLXNB3 gene that are associated with X-linked Adrenoleukodystrophy, a genetic disorder. This condition affects the nervous system and the adrenal glands, leading to a wide range of symptoms, including behavioral changes, loss of function in the adrenal gland, and progressive neurological decline. The test is crucial for early detection and management of the disorder, particularly in families with a history of ALD. Priced at 3200 AED, the test involves analyzing the patient’s DNA to detect mutations in the PLXNB3 gene, providing essential information for diagnosis, treatment planning, and genetic counseling. DNA Labs UAE ensures a comprehensive and reliable testing process, employing advanced genetic testing technologies to assist patients and their families in managing this challenging condition.

Description

PLXNB3 Gene Adrenoleukodystrophy x-linked Genetic Test

Test Name: PLXNB3 Gene Adrenoleukodystrophy x-linked Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 3200.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PLXNB3 Gene Adrenoleukodystrophy, x-linked NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PLXNB3 Gene Adrenoleukodystrophy, x-linked.

Test Details: Adrenoleukodystrophy (ALD) is a rare genetic disorder that affects the nervous system and adrenal glands. It is caused by mutations in the PLXNB3 gene, which is located on the X chromosome. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the analysis of multiple genes at once, including the PLXNB3 gene. This test can identify mutations in the PLXNB3 gene that may be responsible for ALD. The PLXNB3 gene provides instructions for making a protein that is involved in the growth and development of nerve cells and the adrenal gland. Mutations in this gene can disrupt the function of the protein, leading to the symptoms of ALD. Symptoms of ALD can include difficulty with coordination and balance, changes in behavior and cognition, vision loss, and adrenal gland dysfunction. The severity and progression of symptoms can vary widely among individuals with ALD. NGS genetic testing for ALD can help with early diagnosis and management of the condition. Treatment options may include medications to manage symptoms, hormone replacement therapy for adrenal gland dysfunction, and stem cell transplantation in certain cases. It is important to note that ALD is an X-linked disorder, meaning that it primarily affects males. Females can also be carriers of the condition and may have mild symptoms or no symptoms at all. Genetic counseling is recommended for individuals and families with a history of ALD to better understand the risks and options for testing and management.

Test Name	PLXNB3 Gene Adrenoleukodystrophy x-linked Genetic Test
Components
Price	3200.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for PLXNB3 Gene Adrenoleukodystrophy, x-linked NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PLXNB3 Gene Adrenoleukodystrophy, x-linked
Test Details	Adrenoleukodystrophy (ALD) is a rare genetic disorder that affects the nervous system and adrenal glands. It is caused by mutations in the PLXNB3 gene, which is located on the X chromosome. NGS (Next-Generation Sequencing) is a genetic testing method that allows for the analysis of multiple genes at once, including the PLXNB3 gene. This test can identify mutations in the PLXNB3 gene that may be responsible for ALD. The PLXNB3 gene provides instructions for making a protein that is involved in the growth and development of nerve cells and the adrenal gland. Mutations in this gene can disrupt the function of the protein, leading to the symptoms of ALD. Symptoms of ALD can include difficulty with coordination and balance, changes in behavior and cognition, vision loss, and adrenal gland dysfunction. The severity and progression of symptoms can vary widely among individuals with ALD. NGS genetic testing for ALD can help with early diagnosis and management of the condition. Treatment options may include medications to manage symptoms, hormone replacement therapy for adrenal gland dysfunction, and stem cell transplantation in certain cases. It is important to note that ALD is an X-linked disorder, meaning that it primarily affects males. Females can also be carriers of the condition and may have mild symptoms or no symptoms at all. Genetic counseling is recommended for individuals and families with a history of ALD to better understand the risks and options for testing and management.